PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Methanol extract decreased the incidence of OSCC in 4-nitroquinoline-1-oxide induced rat models [PMID:30291495] and induced apoptosis in H400 and H103 cell lines [PMID:27123447, PMID:31176147].
Two isolated chalcone derivatives (2,4'-dihydroxy-4-methoxydihydrochalcone and 2,4'-dihydroxy-4-methoxyhydrochalcone) demonstrated anti-HBV activity [PMID:35164217].
A chitosan-alginate scaffold loaded with D. cinnabari and Aloe Vera showed superior epithelization, collagen deposition, and fibroblast maturation in vivo [PMID:33838800].
Crude extracts exhibited significant antimicrobial activity [PMID:16678369] and in vitro antifungal activity against six human pathogenic fungal strains [PMID:30373099].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 34337055 (2021) — Phytochemistry and Pharmacological Activities of Dracaena cinnabari Resin. · BioMed research international
- 2.PMID: 35164217 (2022) — Isolation and Characterization of Two Chalcone Derivatives with Anti-Hepatitis B Virus Activity from the Endemic Socotraen Dracaena cinnabari (Dragon's Blood Tree). · Molecules (Basel, Switzerland)
- 3.PMID: 31313432 (2019) — Rapid identification of dragon blood samples from Daemonorops draco, Dracaena cinnabari and Dracaena cochinchinensis by MALDI-TOF mass spectrometry. · Phytochemical analysis : PCA
- 4.PMID: 33114517 (2020) — β-Caryophyllene: A Single Volatile Component of n-Hexane Extract of Dracaena cinnabari Resin. · Molecules (Basel, Switzerland)
- 5.PMID: 36202844